Breast Reduction Surgery on the Increase

The Hospital Group has reported that the number of women choosing to have a breast reduction has gone up by 78% since 2005.

The main reason for considering a breast reduction, or reduction mammoplasty is that an over generous bust size can be distressing or uncomfortable.

Large breasts can often be the cause of significant physical discomfort and self-consciousness. Breast reduction surgery could significantly help to relieve the constant backache or shoulder pain associated with big breasts.

Regarding the reductions, a spokesperson for The Hospital Group, said: “We have seen a noticeable rise in women wanting to feel less self-conscious about their bodies. A lot of women with naturally large breasts are embarrassed because of their size and feel insecure as they can attract a lot of unwanted attention.”

The Hospital Group is one of the UK’s leading providers of Plastic Surgery, number one in Obesity Surgery and Breast Enlargement experts. So whatever your requirements, you’re in safe hands!

Since The Hospital Group was established in 1992, it has risen to become the UK’s biggest weight loss surgery providers, performing more gastric band procedures last year than the NHS.

Via EPR Network
More Healthcare press releases

IS Clinical Improperly Using Phytoceuticals Inc Proprietary Research To Sell Products With Proven Quality Issues

PhytoCeuticals, Inc., strongly cautions its customers that some claims being made by IS Clinical about their products improperly uses scientific publications, clinical trials and research that are the exclusive property of PhytoCeuticals, Inc. and its founder, Dr. Mostafa Omar.

Dr. Mostafa Omar, PhytoCeutical’s president, is the highly respected developer and manufacturer of proprietary skin care formulations and the inventor of Stable Liquid L-Ascorbic Acid (Vitamin C).

PhytoCeuticals has developed several formulations, including stabilized liquid L-Ascorbic Acid in 1994. The company had distributed these products through Cellex-C, SkinCeuticals and IS Clinical. PhytoCeuticals permitted these companies the use of these scientific publications, clinical trials and research citations to support the marketing of PhytoCeuticals formulations.

PhytoCeuticals terminated its relationship (July 1, 2008) with IS Clinical by Innovation Skincare (Science of Skincare Inc.). Therefore IS Clinical no longer distributes any products using PhytoCeuticals formulations.

In addition, these companies surrendered the rights to use this materials for advertising and publicity claims. The only legal use of these studies is to support the sale of products formulated or developed by Dr. Omar and PhytoCeuticals, Inc.

PhytoCeuticals continues to retain the ownership of all its proprietary formulations, as well as the scientific research, publications, patents and grants from National Cancer Institute (NCI) and National Institute of Health (NIH).

Since the termination of the business relationship, PhytoCeuticals has received numerous requests from customers who have purchased IS Clinical products, (which do not contain PhytoCeuticals formulations) to exchange these IS Clinical products for genuine PhytoCeuticals PHYTO-C products.

Dr. Omar has stated that, “The acceptance of exchanges of IS Clinical new products for PhytoCeuticals PHYTO-C products was initially a courtesy to patients who thought they were still purchasing our formulations. It is my ethical duty to help and treat these patients – which is more important then making a profit. But we must be fair.”

NEW POLICY
Any purchaser of IS Clinical skincare products who is dissatisfied, should return these products to IS Clinical directly for refunds or substitute products. PhytoCeuticals has no responsibility and does not guarantee IS Clinical products.

PhytoCeuticals is currently is unaware of any controlled clinical testing, stability testing or research undertaken by IS Clinical with respect to the products it has been selling since July 1, 2008.

Dr. Mostafa Omar stated, “Normally a clinical study and testing of a new formulation takes at least 5 years or more before a product is launched into the marketplace. To the extent that IS Clinical claims that it has undertaken extensive research in connection with its products, customers should confirm that the research cited is genuine and not proprietary research using authentic PhytoCeuticals formulations.”

ABOUT PHYTOCEUTICALS
PhytoCeuticals, Inc. is the market leader in antioxidant skin care products. Established by Dr. Mostafa Omar and based in the United States, the company was awarded NCI grant #1 R43- CA83538-01A1 for “Prevention of UV Photoinjury in Skin by Antioxidants”, NCI Grant #1-R43-CA94484-01 for “Photoprotection of Skin by Topical Selenium” , Olive patent # 6,743,499 B2 and Aleoferon patent # 4861761 & NIH.

For further information, please visit www.phyto-ceutical.com or contact us directly at 201-791-2255 or info@phyto-ceutical.com.

Via EPR Network
More Healthcare press releases

Innovative Medical Apparel Company Launches Men’s Lab Coats At Medica 2009 Conference

Medelita®, maker of breakthrough medical apparel, today announced the launch of its men’s lab coats, which are on display at Medica 2009, a leading international trade fair for the medical industry held in Dusseldorf, Germany. Medelita inaugurates its men’s collection with three varying lab coat styles, all named after distinguished figures in medicine: The Osler (44 in.), The Laennec (40 in.) and The Fleming (30 in.).

Men's Lab Coats

“Sophisticated, prestigious, innovative — these are words that medical professionals do not typically associate with lab coats,” said Lara Manchik, founder, Medelita.“But with the introduction of Medelita Men’s lab coats, male clinicians can now enjoy the same designer tailoring, high performance fabrics and upgrades that our female customers have raved about in our lab coats. The arrival of our men’s line is a natural evolution and we are thrilled to bring a product to market that’s long overdue.”

All Medelita lab coats are hand sewn in the U.S. using 100 percent pre-shrunk cotton, representing a significant improvement over traditional polyester/cotton blend lab coats with limited breathability. The lab coats feature a modern tailored fit, with finished inside seams and advanced fabric technology for unparalleled soil, stain, fluid and wrinkle resistance. While each style of Medelita Men’s lab coat is designed for a specific use, they are all available in contemporary menswear sizes 36-52.

The 44-inch Osler men’s lab coat is the modern version of the classic, full-length lab coat. Featuring five total pockets, including a concealed pocket for a PDA or Smartphone, the Osler lab coat is named after Sir William Osler, MD, CM, a Canadian physician, pathologist, educator, bibliophile, historian, and author, who is described as the Father of Modern Medicine.

The 40-inch Laennec lab coat is Medelita’s mid-length lab coat featuring abundant upgrades to this versatile physician lab coat. With a tailored, distinguished look and technically innovative features, this new men’s lab coat was named for René-Théophile-Hyacinthe Laennec, a French physician who invented the stethoscope in 1816, while working at the Hôpital Necker and pioneered its use in diagnosing various chest conditions.

The 30-inch Fleming lab coat is a hip-length lab coat, often called a “consultation” or “student” length lab coat. The Fleming is named after Sir Alexander Fleming, a Scottish biologist and pharmacologist who published many articles on bacteriology, immunology and chemotherapy. He is best-known for receiving the Nobel Peace Prize for the discovery of penicillin, which he shared with two colleagues.

About Medelita
Medelita has one purpose: to reinvent the way women and men of all healthcare professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including women’s lab coats, men’s lab coats, embroidered lab coats and medical scrubs. Medelita caters to medical professionals who want their uniforms to embody the poise and confidence already displayed from within. For more information, visit our websites at http://www.medelita.com or http://www.medelita-mens.com, or call 877.987.7979.

Via EPR Network
More Healthcare press releases